These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1816213)

  • 1. Platelet adhesiveness and fibrinolytic activity in diabetes mellitus before and after therapy.
    Narang NK; Meratwal S; Jain PC
    J Assoc Physicians India; 1991 Oct; 39(10):784. PubMed ID: 1816213
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic activity of a glibenclamide-phenformin association in maturity-onset diabetes].
    Gervasini A
    Minerva Med; 1974 Oct; 65(73):3835-42. PubMed ID: 4214284
    [No Abstract]   [Full Text] [Related]  

  • 3. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P; Mughini L
    Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolytic response to moderate exercise and platelet adhesiveness in diabetes mellitus.
    Seth HN
    Acta Diabetol Lat; 1973; 10(2):306-14. PubMed ID: 4744226
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolytic response to moderate exercise and platelet adhesiveness in diabetes mellitus].
    Seth HN
    Acta Diabetol Lat; 1973; 10(2):306-314. PubMed ID: 4741835
    [No Abstract]   [Full Text] [Related]  

  • 6. [Initial results in the treatment of diabetes mellitus with an association of glibenclamide and phenformin].
    Carta Q; Pugliese F
    Minerva Med; 1974 Jan; 65(1):27-57. PubMed ID: 4214410
    [No Abstract]   [Full Text] [Related]  

  • 7. [Daily curves of blood sugar and serum insulin after treatment with various combinations of glibenclamide and phenformin].
    Giangrandi E; Scaroina F; Tommasini-Degna C
    Minerva Med; 1975 Mar; 66(19):940-5. PubMed ID: 804684
    [No Abstract]   [Full Text] [Related]  

  • 8. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Postiglione F; Verdoliva A; Schiraldi F
    Clin Ter; 1974 Jul; 70(2):147-51. PubMed ID: 4212848
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.
    Bielawiec M; Myśliwiec M; Perzanowski A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):483-8. PubMed ID: 4139068
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis of recurrent venous thrombosis with long-term enhancement of fibrinolysis.
    Bielawiec M; Lukjan H; Myśliwiec M; Dabrowski S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):971-6. PubMed ID: 94894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Fibrinolytic activity in treatment of diabetes.
    Bogie W; George J; Crane CW
    Lancet; 1976 Aug; 2(7980):312. PubMed ID: 59882
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet adhesiveness in diabetics.
    Bielawiec M; Myśliwiec M; Perzanowski A
    Pol Med J; 1970; 9(5):1071-5. PubMed ID: 5510276
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological fibrinolysis in occlusive vascular disease and its relation to diabetes mellitus.
    Fearnley GR
    Postgrad Med J; 1969 May; 45():52-62. PubMed ID: 5364315
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glibenclamide, a new oral antidiabetic].
    Edlén A
    Lakartidningen; 1972 Jan; 69(4):342-3. PubMed ID: 4622487
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of long-term therapy with phenformin plus metanabol on blood fibrinolytic activity, platelet adhesiveness and lipid metabolism in patients with arteriosclerosis.
    Perzanowski A; Bielawiec M; Myśliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):381-8. PubMed ID: 63425
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of fibrinolytic and platelet activities in diabetics].
    Abastado M; Doumenc J; Prost R; Casubolo L; Samama M; Derot M; Bousser J
    Diabete; 1967; 15(2):119-26. PubMed ID: 5607436
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of blood clotting and fibrinolytic disorders in diabetics in the development of pathological changes in blood vessels].
    Chmielewski J
    Wiad Lek; 1973 Apr; 26(7):615-7. PubMed ID: 4573502
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with glibenclamide in long-term treatment of diabetes mellitus.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1976 Feb; 19(2):237-41. PubMed ID: 813962
    [No Abstract]   [Full Text] [Related]  

  • 19. [Glibenclamide-phenformin combination in the treatment of diabetes in adults].
    Pittera A; Ruvolo F; Di Blasi F
    Clin Ter; 1975 Aug; 74(3):231-58. PubMed ID: 819201
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of phenphormin on blood fibrinolysis in diabetes mellitus.
    Fiaschi E; Barbui T; Previato G; Di Luzio V; Guarnieri GF; Todesco S
    Arzneimittelforschung; 1969 Apr; 19(4):638-40. PubMed ID: 5819165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.